NasdaqCM - Delayed Quote USD
NeuroSense Therapeutics Ltd. (NRSNW)
0.2500
+0.0010
+(0.40%)
At close: May 7 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
4,575
3,185
7,710
11,431
Total Liabilities Net Minority Interest
1,992
4,944
2,091
2,425
Total Equity Gross Minority Interest
2,583
-1,759
5,619
9,006
Total Capitalization
2,583
-1,759
5,619
9,006
Common Stock Equity
2,583
-1,759
5,619
9,006
Capital Lease Obligations
73
142
211
0
Net Tangible Assets
2,583
-1,759
5,619
9,006
Working Capital
2,410
-543
5,655
10,815
Invested Capital
2,583
-1,759
5,619
9,006
Tangible Book Value
2,583
-1,759
5,619
9,006
Total Debt
73
142
211
0
Share Issued
23,228.9410
15,379.0420
11,781.9630
10,943.5340
Ordinary Shares Number
23,228.9410
15,379.0420
11,781.9630
10,943.5340
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLAW Estrella Immunopharma, Inc.
0.0807
-4.16%
DRTSW Alpha Tau Medical Ltd.
0.1849
0.00%
CINGW Cingulate Inc.
0.0390
-2.50%
TVGNW Tevogen Bio Holdings Inc.
0.0435
-11.22%
OCEAW Ocean Biomedical, Inc.
0.0026
-71.11%
ZVSA ZyVersa Therapeutics, Inc.
0.6848
+24.24%
IOBT IO Biotech, Inc.
0.9850
-7.94%
CLRB Cellectar Biosciences, Inc.
0.2442
+1.41%
ITRM Iterum Therapeutics plc
0.9221
-7.48%
CRDF Cardiff Oncology, Inc.
2.4900
-2.35%